Related Experiment Videos

An essential domain of the c-myc protein interacts with a nuclear factor that is also required for E1A-mediated

D E Brough1, T J Hofmann, K B Ellwood

  • 1Department of Molecular Biology, Princeton University, New Jersey 08544.

Insights

A specific domain in the c-Myc protein (amino acids 129-145) is crucial for cell transformation and interacts with a nuclear factor essential for both c-Myc and adenovirus E1A oncogene activity.

Area of Science:

  • Molecular Biology
  • Oncology
  • Virology

Background:

  • Nuclear oncogenes like c-Myc drive cell transformation by activating target genes involved in cell division.
  • Understanding the precise mechanisms of oncogene function is critical for cancer research.

Purpose of the Study:

  • To investigate the role of a conserved domain (amino acids 129-145) within the c-Myc protein in cell transformation and transcriptional activation.
  • To explore the relationship between this domain, nuclear factor interaction, and oncogenic activity.

Main Methods:

  • Analyzing the effects of deleting or mutating amino acids 129-145 in the c-Myc gene on cell transformation.
  • Using GAL4 fusion proteins to assess transcriptional activation and dominant inhibitory effects.
  • Investigating protein-protein interactions using complex formation assays in Cos cells.

Main Results:

  • Deletion or mutation of the 129-145 domain inactivated c-Myc's transforming ability while retaining transcriptional activation.
  • This domain is essential for the dominant negative effects of GAL4-Myc on c-Myc and E1A-mediated transformation.
  • The c-Myc N-terminus forms a specific complex with a nuclear factor, which is disrupted by mutations in the 129-145 domain.

Conclusions:

  • The c-Myc 129-145 domain is essential for oncogenic transformation and interacts with a nuclear factor.
  • This nuclear factor is also required for adenovirus E1A-mediated transformation, suggesting a common pathway.
  • Targeting this interaction could offer new therapeutic strategies for cancers driven by c-Myc or related pathways.

Related Concept Videos